TP53 and gastric cancer: Network pharmacological analysis predicted that the major components of S. baicalensis for the treatment of GC include wogonin, baicalein, acacetin, moslosooflavone, and oroxylin A, and that the major pathways are the PI3K-Akt, P53, and VEGF pathways.